YARTEMLEA 370 mg/2mL
narsoplimab · INJECTION · Omeros Corporation
No Recall History
Plain English
YARTEMLEA is a injection containing narsoplimab at 370 mg/2mL, taken intravenous. Manufactured by Omeros Corporation.
Key Facts
- Brand Name
- YARTEMLEA
- Generic Name
- narsoplimab
- NDC Code (Product)
62225-300- Manufacturer
- Omeros Corporation
- Strength
- 370 mg/2mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761152
- Marketing Start
- 01/20/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is YARTEMLEA used for?
YARTEMLEA contains narsoplimab. It is a injection taken intravenous. Consult your doctor for specific uses.
Is YARTEMLEA a controlled substance?
YARTEMLEA is not classified as a controlled substance by the DEA.
What is the generic name for YARTEMLEA?
The generic name for YARTEMLEA is narsoplimab. There are no other listed brand versions of narsoplimab.
What is the NDC code for YARTEMLEA 370 mg/2mL?
The NDC (National Drug Code) for YARTEMLEA 370 mg/2mL is 62225-300, listed by Omeros Corporation.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)